Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELTROMBOPAG OLAMINE Cause Ocular hyperaemia? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Ocular hyperaemia have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.1% of all adverse event reports for ELTROMBOPAG OLAMINE.

16
Reports of Ocular hyperaemia with ELTROMBOPAG OLAMINE
0.1%
of all ELTROMBOPAG OLAMINE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Ocular hyperaemia From ELTROMBOPAG OLAMINE?

Of the 16 reports, 1 (6.3%) resulted in death, 4 (25.0%) required hospitalization, and 3 (18.8%) were considered life-threatening.

Is Ocular hyperaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?

Platelet count decreased (3,419) Death (2,797) Drug ineffective (1,117) Platelet count increased (980) Fatigue (868) Headache (750) Nausea (584) Diarrhoea (558) Product use in unapproved indication (545) Malaise (516)

What Other Drugs Cause Ocular hyperaemia?

DUPILUMAB (6,938) CYCLOSPORINE (1,508) BIMATOPROST (1,447) CENEGERMIN-BKBJ (1,226) BRIMONIDINE (917) ADALIMUMAB (714) LATANOPROST (587) DORZOLAMIDE\TIMOLOL (581) LIFITEGRAST (570) TRAVOPROST (478)

Which ELTROMBOPAG OLAMINE Alternatives Have Lower Ocular hyperaemia Risk?

ELTROMBOPAG OLAMINE vs ELUXADOLINE ELTROMBOPAG OLAMINE vs ELVITEGRAVIR ELTROMBOPAG OLAMINE vs EMAPALUMAB ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG ELTROMBOPAG OLAMINE vs EMEND

Related Pages

ELTROMBOPAG OLAMINE Full Profile All Ocular hyperaemia Reports All Drugs Causing Ocular hyperaemia ELTROMBOPAG OLAMINE Demographics